Co-Founder and CEO, Phosphorous
Alexander Bisignano serves as the Chief Executive Officer for Phosphorus. Alex is responsible for long-term direction and development of Phosphorus diagnostic tests, software, and research initiatives. Before Phosphorus, Alex co-founded Recombine, a clinical genetic testing company, which was acquired by CooperSurgical in May of 2016. At Phosphorus and Recombine Alex helped develop novel genotyping and next-generation sequencing platforms for clinical genetics. His work has been presented at the American Society for Reproductive Medicine, the European Society for Human Reproduction and Embryology and a number of other scientific programs. Alex has also appeared on Fox Business and Bloomberg TV as an expert in the genetic testing market. Alex received his B.A. in molecular biology from Princeton University and is a member of Sigma Xi, the Scientific Research Society.
A Distributed Clinical Data Network: Enabling Adoption of NGS
Precision medicine promises a world where healthcare is powered by genomics. Yet labs face challenges due to isolated data stores, lack of standardization, and an ever-changing technology landscape. Clinical NGS software can create distributed clinical data networks of members around the globe who benefit from an ecosystem of data sharing that alleviates the challenges of delivering advanced clinical genetic tests.